There have been several reports that the antibodies to treat Covid patients just sit on the shelves

[question everything]

no one is using them. Also, it does not appear that Remdesivir is being used. Why not?

With death rate continues to rise?

[Phoenix61]

1. The issue with the antibody treatment is it is

a two hour infusion like chemo. Obviously can’t use facilities where cancer patients are being given chemo. They need to set up special infusion treatment centers close enough to a hospital in case of a bad reaction. No idea about the drug.

[bullimiami]

4. i dont think the remdesivir does anything. You give it, some people recover.

You dont give it, some people recover. Another scam like the hydroxy.

[question everything]

5. It does. From a recent NEJM paper

Remdesivir for the Treatment of Covid-19 — Final Report

https://www.nejm.org/doi/full/10.1056/NEJMoa2007764

Our data show that remdesivir was superior to placebo in shortening the time to recovery in adults who were hospitalized with Covid-19 and had evidence of lower respiratory tract infection. (Funded by the National Institute of Allergy and Infectious Diseases and others; ACTT-1 ClinicalTrials.gov number, NCT04280705. opens in new tab.)

[bullimiami]

7. Superior to placebo is not a glowing recommendation. But apparently it does something. Thx.

[dewsgirl]

2. Because it's intentional. (I know that would have sounded nuts a year ago,

alas here we are)

[Hoyt]

3. Here's a good article with several reasons discussed including need to

have treatment early. Even says many providers aren’t aware, for those who think doctors stay up-to-date.

https://www.nbcnews.com/health/health-news/monoclonal-antibodies-could-ease-record-covid-hospitalizations-why-are-they-n1254271

[question everything]

6. Simply put, a lack of time, resources and awareness - from the link

And yet, patients are dying at an accelerated rate.

And then, Azar, again, with the promise of "Vaccines stockpile"

During a media briefing Tuesday, Health and Human Services Secretary Alex Azar put the onus for pursuing monoclonal antibodies on patients, who "should be asking their doctors or health care providers why they aren't being offered these antibody therapies."

He really should be charged.

But still hope? From the link, again:

Some standalone kidney dialysis centers across the country have announced that they will begin administering monoclonal antibodies to Covid-19 patients during shifts set up for only those patients. Covid-19 has been shown to be especially dire for patients with kidney disease.